Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.48 |
| ▸ | TOP1 | P11387 | 3/20 | 0.43 |
| ▸ | CYCS | P99999 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.35 |
| ▸ | TERT | O14746 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12392075 | 1.00 | ABCG2 (0.48) | ABCG2TOP1CYCSMAPTSMN1; SMN2 | |
| SCHEMBL12451490 | 1.00 | ABCG2 (0.48) | ABCG2TOP1CYCSMAPTSMN1; SMN2 | |
| SCHEMBL17688989 | 0.98 | ABCG2 (0.50) | ABCG2TOP1CYCSMAPTSMN1; SMN2 | |
| SCHEMBL12450828 | 0.98 | ABCG2 (0.45) | ABCG2TOP1CYCSMAPTSMN1; SMN2 | |
| SCHEMBL12392100 | 0.98 | ABCG2 (0.45) | ABCG2TOP1CYCSMAPTSMN1; SMN2 | |
| SCHEMBL24689574 | 0.98 | ABCG2 (0.50) | ABCG2TOP1CYCSMAPTSMN1; SMN2 | |
| SCHEMBL17688987 | 0.97 | ABCG2 (0.46) | ABCG2TOP1CYCSMAPTSMN1; SMN2 | |
| SCHEMBL17689321 | 0.97 | ABCG2 (0.46) | ABCG2TOP1CYCSMAPTSMN1; SMN2 | |
| SCHEMBL12451489 | 0.96 | ABCG2 (0.52) | ABCG2TOP1CYCSMAPTSMN1; SMN2 | |
| SCHEMBL12392069 | 0.96 | ABCG2 (0.52) | ABCG2TOP1CYCSMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9315510-B2 | Method and application of unsymmetrically meso-substituted porphyrins and chlorins for PDT | BIOLITEC PHARMA MARKETING LTD (MY) | 2016-04-19 | — | — | US | disclosed |
| US-9315510-B2 | Method and application of unsymmetrically meso-substituted porphyrins and chlorins for PDT | BIOLITEC PHARMA MARKETING LTD (MY) | 2016-04-19 | — | — | US | disclosed |